Background: The Occlutech Atrial Flow Regulator (AFR) is a self-expandable double-disc nitinol device with a central fenestration. Its use has been approved in the adult population with heart failure and described for pulmonary hypertension (PH). Only case reports and small series have been published about its use in the paediatric population and for congenital heart disease (CHD).Objectives: The authors sought to investigate the feasibility, safety, and short-term follow-up of AFR implantation in patients with CHD or children with PH or cardiomyopathy.Methods: This is a multicenter retrospective study involving 10 centers worldwide. Patients of any age with CHD or patients aged < 18 years with PH or cardiomyopathy needing AFR implantation were included.Results: A total of 40 patients underwent AFR implantation. The median age of the population at the time of the procedure was 58.5 months (IQR: 31.5–142.5) and the median weight was 17 kg (IQR: 10–46). A total of 26 (65.0%) patients had CHD, nine (22.5%) children, a cardiomyopathy, and five (12.5%), a structurally normal heart. The implantation success rate was 100%. There were two early and one late device thrombosis. Two patients (5.0%) with dilated cardiomyopathy on extracorporeal membrane oxygenator (ECMO) died during the hospital stay. At a median follow-up of 330 days (IQR: 125–593), 37 (92.5%) patients were alive. At follow-up, 20 patients improved their New York Heart Association (NYHA) class, 12 patients did not change their NYHA class, and one patient with idiopathic PH worsened.Conclusions: AFR implantation in patients with CHD and children with severe PH or cardiomyopathy is promising and seems to have beneficial effects at short-term follow-up.
Influence of sex and age on manifestations of sinonasal symptoms in children and adolescents with comorbid course of allergic rhinitis (AR) and bronchial asthma (BA) remains unstudied. Objective. To study age-related and sex-specific influence on the domains of validated SNOT-22 (Syno-Nasal Outcome Test 22) questionnaire domains in children and adolescents with comorbid course of BA and AR. Patients and methods. The number of patients with BA and AR equal 214 aged from 5 to 17 years was examined. The following periods were identified according to the age: childhood (CH) — up to 9 years old; early adolescence (EA) — from 10 to 14 years old; middle adolescence (MA) — from 15 to 17 years old. Sinonasal symptoms were assessed by means of the SNOT-22 and with assignment of rhinological and non-rhinological blocks of questions in each patient. Results. Totally, the sum of SNOT-22 scores was statistically significantly higher in patients in MA compared to CH and EA in the general group of patients (p=0.006) and in the group of girls (p=0.003), but not in the group of boys (p=0.35). Rhinological domain values increased as patients got older regardless of sex (all p0.05), however a tendency towards symptoms increasing in girls (p=0.09) has been noted. Patients with cystic polypoid changes in the mucosa of the nose and/or paranasal sinuses had the highest values of total SNOT-22 score. Conclusion. Sex and age may have a modifying effect on the SNOT-22 sinonasal test scores in children and adolescents with BA and AR.
23 April 2024 in Russian Bulletin of Otorhinolaryngology
Relevance. Nasal congestion is one of the most common complaints in otolaryngology practice and can significantly impact the quality of life for patients. Objective and subjective assessments provide different information, but objective assessment of nasal obstruction is crucial for accurate diagnosis and appropriate treatment. This review demonstrates that peak nasal inspiratory flow (PNIF) is a reproducible and reliable measure of objective nasal patency. It is inexpensive, easy to use, suitable for serial measurements, and can be applied to patients of different age groups. PNIF is recommended for use in every outpatient clinic that treats patients with nasal congestion. Objective. To summarize the data on the application of PNIF in diagnosing conditions of the nasal airways. Material and methods. Publications (articles and relevant abstracts) available in the PubMed and eLibrary databases were analyzed. Conclusion. PNIF offers an objective and non-invasive assessment of nasal airflow, aiding in diagnosis, therapy monitoring, and preoperative planning. Further research, standardization, and establishment of normative data will enhance the informative value of peak nasal inspiratory flow in assessing nasal obstruction.
Aim: Cough is an important symptom of the combined course of bronchial asthma (BA) and allergic rhinitis (AR) and/or allergic rhinosinusitis (ARS), but the contribution of the pathology of the upper and lower airway to the formation of cough in these patients cannot be considered established. The aim of the study was to evaluate the relationship of cough intensity with indicators of external respiration and nasal respiratory function in children and adolescents with a combined course of BA and AR and/or ARS. Methods: It was a single-center observational transverse pilot study. The absence and/or presence of cough and its intensity were scored in 122 patients (14.0 [11.0; 16.0] years) using the Sinonasal Outcome Test–22 (SNOT-22). Groups were identified: 1 (n = 29)—no cough (0 points), 2 (n = 72)—mild cough (1–2 points), 3 (n = 21)—moderate cough (3–4 points). Peak nasal inspiratory flow (PNIF) and spirometric parameters were measured. Results: Assessment of cough by patients using the SNOT-22 test had negative correlations with spirometric indicators: z FEV1 and z FEV1/FVC (r = –0.23, P = 0.012, and r = –0.21 P = 0.023, respectively). A positive relationship was noted with changes in FEV1 in tests with bronchodilators (r = 0.43, P = 0.002) and with the severity of postnasal drip (r = 0.45, P < 0.001 and r = 0.43, P < 0.001, respectively). Conclusions: Established correlations of cough intensity with spirometry indicators and with symptoms of postnasal drip in patients with combined BA and AR/ARS indicate the participation of both the upper and lower respiratory tract in the formation of cough.
11 April 2024 in Pediatria. Journal named after G.N. Speransky